Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia

about

Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia

Item

http://www.wikidata.org/entity/Q58699510

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@en

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@nl

type

Item

label

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@en

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@nl

prefLabel

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@en

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@nl

P1476

Novel AF1q/MLLT11 favorably af ...... al in chronic myeloid leukemia

@en

P2093

Chunyan Ji

http://www.w3.org/2001/XMLSchema#string

Daoxin Ma

http://www.w3.org/2001/XMLSchema#string

Fei Lu

http://www.w3.org/2001/XMLSchema#string

Jingjing Ye

http://www.w3.org/2001/XMLSchema#string

Jingru Zhang

http://www.w3.org/2001/XMLSchema#string

Min Ji

http://www.w3.org/2001/XMLSchema#string

Peng Li

http://www.w3.org/2001/XMLSchema#string

Shaolei Zang

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Xin Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway

CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells

Survival regulation of leukemia stem cells

High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

The molecular biology of chronic myeloid leukemia.

JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.

CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells

P2888

s41419-018-0900-7

P304

855

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41419-018-0900-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106390998

http://www.w3.org/2001/XMLSchema#string

P698

30154435

http://www.w3.org/2001/XMLSchema#string

P921

immunology

leukemia

cancer research

P932

6113287

http://www.w3.org/2001/XMLSchema#string